beta-cyclodextrin/epoxysuccinyl peptide conjugates: new drug targeting system for tumor cells

Schaschke N, Assfalg-Machleidt I, Machleidt W, Lassleben T, Sommerhoff CP, Moroder L (2000)
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS 10(7): 677-680.

Journal Article | Published | English

No fulltext has been uploaded

Author
; ; ; ; ;
Publishing Year
ISSN
PUB-ID

Cite this

Schaschke N, Assfalg-Machleidt I, Machleidt W, Lassleben T, Sommerhoff CP, Moroder L. beta-cyclodextrin/epoxysuccinyl peptide conjugates: new drug targeting system for tumor cells. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS. 2000;10(7):677-680.
Schaschke, N., Assfalg-Machleidt, I., Machleidt, W., Lassleben, T., Sommerhoff, C. P., & Moroder, L. (2000). beta-cyclodextrin/epoxysuccinyl peptide conjugates: new drug targeting system for tumor cells. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 10(7), 677-680.
Schaschke, N., Assfalg-Machleidt, I., Machleidt, W., Lassleben, T., Sommerhoff, C. P., and Moroder, L. (2000). beta-cyclodextrin/epoxysuccinyl peptide conjugates: new drug targeting system for tumor cells. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS 10, 677-680.
Schaschke, N., et al., 2000. beta-cyclodextrin/epoxysuccinyl peptide conjugates: new drug targeting system for tumor cells. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 10(7), p 677-680.
N. Schaschke, et al., “beta-cyclodextrin/epoxysuccinyl peptide conjugates: new drug targeting system for tumor cells”, BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, vol. 10, 2000, pp. 677-680.
Schaschke, N., Assfalg-Machleidt, I., Machleidt, W., Lassleben, T., Sommerhoff, C.P., Moroder, L.: beta-cyclodextrin/epoxysuccinyl peptide conjugates: new drug targeting system for tumor cells. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS. 10, 677-680 (2000).
Schaschke, Norbert, Assfalg-Machleidt, I, Machleidt, W, Lassleben, T, Sommerhoff, CP, and Moroder, L. “beta-cyclodextrin/epoxysuccinyl peptide conjugates: new drug targeting system for tumor cells”. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS 10.7 (2000): 677-680.
This data publication is cited in the following publications:
This publication cites the following data publications:

10 Citations in Europe PMC

Data provided by Europe PubMed Central.

Cyclodextrin-peptide conjugates for sequence specific DNA binding.
Ruiz Garcia Y, Zelenka J, Pabon YV, Iyer A, Budesinsky M, Kraus T, Smith CI, Madder A., Org. Biomol. Chem. 13(18), 2015
PMID: 25857557
New glycoside derivatives of carnosine and analogs resistant to carnosinase hydrolysis: synthesis and characterization of their copper(II) complexes.
Lanza V, Bellia F, D'Agata R, Grasso G, Rizzarelli E, Vecchio G., J. Inorg. Biochem. 105(2), 2011
PMID: 21194616
Click synthesis of estradiol-cyclodextrin conjugates as cell compartment selective estrogens.
Kim HY, Sohn J, Wijewickrama GT, Edirisinghe P, Gherezghiher T, Hemachandra M, Lu PY, Chandrasena RE, Molloy ME, Tonetti DA, Thatcher GR., Bioorg. Med. Chem. 18(2), 2010
PMID: 20031420
Synthesis and pharmacological evaluation of a new targeted drug carrier system: beta-cyclodextrin coupled to oxytocin.
Bertolla C, Rolin S, Evrard B, Pochet L, Masereel B., Bioorg. Med. Chem. Lett. 18(6), 2008
PMID: 18296049
Cyclodextrin/imatinib complexation: binding mode and charge dependent stabilities.
Beni S, Szakacs Z, Csernak O, Barcza L, Noszal B., Eur J Pharm Sci 30(2), 2007
PMID: 17145172
1,2,4-thiadiazole: a novel Cathepsin B inhibitor.
Leung-Toung R, Wodzinska J, Li W, Lowrie J, Kukreja R, Desilets D, Karimian K, Tam TF., Bioorg. Med. Chem. 11(24), 2003
PMID: 14642597
Epoxysuccinyl peptide-derived cathepsin B inhibitors: modulating membrane permeability by conjugation with the C-terminal heptapeptide segment of penetratin.
Schaschke N, Deluca D, Assfalg-Machleidt I, Hohneke C, Sommerhoff CP, Machleidt W., Biol. Chem. 383(5), 2002
PMID: 12108551
Bivalent inhibition of human beta-tryptase.
Schaschke N, Matschiner G, Zettl F, Marquardt U, Bergner A, Bode W, Sommerhoff CP, Moroder L., Chem. Biol. 8(4), 2001
PMID: 11325588

Export

0 Marked Publications

Open Data PUB

Web of Science

View record in Web of Science®

Sources

PMID: 10762052
PubMed | Europe PMC

Search this title in

Google Scholar